Agree to Disagree: Debating Today's Biggest Political Stories
Roy Moore's loss in the Senate election in Alabama came as a surprise to many. It means that Republicans will have an even smaller margin of error when it comes to passing legislation. But, in the long run, how will this impact the GOP? John Iadarola, Host at The Young Turks, and Nick Givas, Media Reporter at The Daily Caller, debate whether Moore's loss is a good or bad thing for the Republican party.
Roy Moore was one of the candidates nationwide who received the strong backing of Steve Bannon and, eventually, President Trump. The round table debates whether President Trump will avoid coming out in support of future Bannon-backed candidates. Iadarola and Givas both agree that it's not likely.
The Russia investigation has been heating up in recent weeks. Many people wonder if President Trump will fire Robert Mueller and take him off the case, especially since Congress will be on recess for the holidays over the next few weeks. While he doesn't believe it will happen during the holidays, Iadarola says it's likely Mueller will be kicked to the curb eventually.
Manhattan District Attorney Alvin Bragg filed a federal lawsuit against Rep. Jim Jordan on Tuesday, accusing the Republican of a “transparent campaign to intimidate and attack” him over his prosecution of former President Donald Trump.
Nashville’s governing council voted Monday to send Justin Jones straight back to the Legislature four days after he was expelled for his role in a protest on the state House floor.
The Justice Department is calling a Texas court ruling that would halt approval of the most commonly used method of abortion in the U.S. "extraordinary and unprecedented."
Nashville city councilors will likely appoint Justin Jones to his former seat on Monday while Memphis-area county commissioners will soon announce when they'll meet to fill the vacancy left by the expulsion of Justin Pearson, which Pearson himself is eligible to fill.
Health and Human Services Secretary Xavier Becerra said "Everything is on the table" when asked if he'd recommend that the FDA ignore Friday's ruling to reverse the agency's nearly 23-year-old approval of the medication abortion drug mifepristone.
